-
-
-
-
-
-
-
B.Riley Starts Vanda Pharmaceuticals (VNDA) at Buy
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Vanda Pharmaceuticals (VNDA)
-
-
-
-
-
-
-
Vanda Pharmaceuticals Announces FDA Update for supplemental NDA for HETLIOZĀ® in the Treatment of Insomnia
-
-
-
-
-
-
-
Vanda Pharmaceuticals Announces that U.S. Food and Drug Administration Accepts New Drug Application for Tradipitant for the Treatment of Gastroparesis
-
-
-
-
-
-
-
Vanda Pharmaceuticals (VNDA) Reports FDA Identified Deficiencies in Review of sNDA for HETLIOZ in Treatment of Jet Lag Disorder
-
-
-
-
-
-
-
Vanda Pharmaceuticals Reports First Quarter 2016 Financial Results
-
-
-
14,982 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

